Inventor · disambiguated record
Jonathan Kipnis
Also filed as: KIPNIS JONATHAN
10 granted patents·14 pending applications·146 citations·filing 2001–2022
86Inventor score
Files withUNIV VIRGINIA PATENT FOUNDATION7YEDA RES & DEV6EISENBACH-SCHWARTZ MICHAL5WASHINGTON UNIVERSITY ST LOUIS3UNIV DUKE1
Top patents by PatentIndex Score
24 records- 0194US6844314B2Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapyYEDA RES & DEV·Filed 2001·Granted Jan 18, 2005·95 cites·43 claims
- 0292US7407936B2Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapyYEDA RES & DEV·Filed 2005·Granted Aug 5, 2008·27 cites·27 claims
- 0380US7351686B2Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptidesYEDA RES & DEV·Filed 2002·Granted Apr 1, 2008·21 cites·11 claims
- 0473US11312775B2Methods for treatment or prevention of a neurological immunity disorderUNIV VIRGINIA PATENT FOUNDATION·Filed 2018·Granted Apr 26, 2022·1 cites·5 claims
- 0572US8828404B2Vaccine and method for treatment of neurodegenerative diseasesEISENBACH-SCHWARTZ MICHAL·Filed 2011·Granted Sep 9, 2014·2 cites·17 claims
- 0660US9517256B2Vaccine and method for treatment of neurodegenerative diseasesYEDA RES & DEV·Filed 2014·Granted Dec 13, 2016·0 cites·24 claims
- 0759US2024238341A1Neuroprotective compositions and methodsWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 0859US2024238338A1Therapeutic application of skull bone marrow and brain border-derived cellsWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 0958US2024415930A1Compositions and methods for enhancing brain perfusionWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 1055US11679104B2Compositions and methods of enhancing the homing and/or engraftment of hematopoietic cells in the central nervous systemUNIV DUKE·Filed 2018·Granted Jun 20, 2023·0 cites·9 claims
- 1154US2010168085A1Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cellsYESA RES AND DEV CO LTD AT THE·Filed 2004·Application pending·0 cites
- 1252US2008085269A1Vaccine And Method For Treatment Of Neurodegenerative DiseasesEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 1352US2011117115A1Method and vaccine comprising copolymer 1 for treatment of psychiatric disordersEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 1449US2018207249A1Method and vaccine comprising copolymer 1 for treatment of psychiatric disordersYEDA RES & DEV·Filed 2017·Application pending·0 cites
- 1548US2009191173A1Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1EISENBACH-SCHWARTZ MICHAL·Filed 2005·Application pending·0 cites
- 1644US2016213762A1Method and vaccine comprising copolymer 1 for treatment of psychiatric disordersYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 1744US2012135016A1Induction of neurogenesis and stem cell therapy in combination with copolymer 1EISENBACH-SCHWARTZ MICHAL·Filed 2011·Application pending·0 cites
- 1843US11389509B1Methods for treatment of social dysfunction neurological disorders and seizuresUNIV VIRGINIA PATENT FOUNDATION·Filed 2018·Granted Jul 19, 2022·0 cites·3 claims
- 1943US2024050529A1Modulating lymphatic vessels in neurological diseaseUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2043US2022119532A1Use of integrin inhibitors for treatment or prevention of a neurological immunity disorder and/or nervous system injuryUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2142US2023067811A1Modulating lymphatic vessels in neurological diseaseUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 2241US12352767B2Method of treating cognitive decline associated with neurological diseases based on a decrease in FLT4 expression or activityUNIV VIRGINIA PATENT FOUNDATION·Filed 2019·Granted Jul 8, 2025·0 cites·13 claims
- 2339US11944665B2Methods and compositions for modulating lymphatic vessels in the central nervous systemUNIV VIRGINIA PATENT FOUNDATION·Filed 2017·Granted Apr 2, 2024·0 cites·3 claims
- 2435US2002037848A1Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Kipnis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →